Cargando…
An Updated Review Summarizing the Anticancer Efficacy of Melittin from Bee Venom in Several Models of Human Cancers
Apitherapy (using bee products) has gained broad recognition in cancer therapeutics globally. Honeybee venom has a broad range of biological potential, and its utilization is rapidly emerging in apitherapy. Bee products have significant potential to strengthen the immune system and improve human hea...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10385528/ https://www.ncbi.nlm.nih.gov/pubmed/37513529 http://dx.doi.org/10.3390/nu15143111 |
_version_ | 1785081429768536064 |
---|---|
author | Pandey, Pratibha Khan, Fahad Khan, Minhaj Ahmad Kumar, Rajnish Upadhyay, Tarun Kumar |
author_facet | Pandey, Pratibha Khan, Fahad Khan, Minhaj Ahmad Kumar, Rajnish Upadhyay, Tarun Kumar |
author_sort | Pandey, Pratibha |
collection | PubMed |
description | Apitherapy (using bee products) has gained broad recognition in cancer therapeutics globally. Honeybee venom has a broad range of biological potential, and its utilization is rapidly emerging in apitherapy. Bee products have significant potential to strengthen the immune system and improve human health. Thus, this review is targeted toward recapitulating the chemo-preventive potential of melittin (MEL), which constitutes a substantial portion of honeybee venom. Honeybee venom (apitoxin) is produced in the venom gland of the honeybee abdomen, and adult bees utilize it as a primary colony defense mechanism. Apitoxin comprises numerous biologically active compounds, including peptides, enzymes, amines, amino acids, phospholipids, minerals, carbohydrates, and volatile components. We are mainly focused on exploring the potential of melittin (a peptide component) of bee venom that has shown promising potential in the treatment of several human cancers, including breast, stomach, lung, prostate, ovary, kidney, colon, gastric, esophageal, cervical cancers, melanoma, osteosarcoma, and hepatocellular carcinoma. This review has summarized all potential studies related to the anticancerous efficacy of melittin (apitoxin), its formulations, conjugates, and nano-formulations against several human carcinomas, which would further pave the way for future researchers in developing potent drugs for cancer management. |
format | Online Article Text |
id | pubmed-10385528 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-103855282023-07-30 An Updated Review Summarizing the Anticancer Efficacy of Melittin from Bee Venom in Several Models of Human Cancers Pandey, Pratibha Khan, Fahad Khan, Minhaj Ahmad Kumar, Rajnish Upadhyay, Tarun Kumar Nutrients Review Apitherapy (using bee products) has gained broad recognition in cancer therapeutics globally. Honeybee venom has a broad range of biological potential, and its utilization is rapidly emerging in apitherapy. Bee products have significant potential to strengthen the immune system and improve human health. Thus, this review is targeted toward recapitulating the chemo-preventive potential of melittin (MEL), which constitutes a substantial portion of honeybee venom. Honeybee venom (apitoxin) is produced in the venom gland of the honeybee abdomen, and adult bees utilize it as a primary colony defense mechanism. Apitoxin comprises numerous biologically active compounds, including peptides, enzymes, amines, amino acids, phospholipids, minerals, carbohydrates, and volatile components. We are mainly focused on exploring the potential of melittin (a peptide component) of bee venom that has shown promising potential in the treatment of several human cancers, including breast, stomach, lung, prostate, ovary, kidney, colon, gastric, esophageal, cervical cancers, melanoma, osteosarcoma, and hepatocellular carcinoma. This review has summarized all potential studies related to the anticancerous efficacy of melittin (apitoxin), its formulations, conjugates, and nano-formulations against several human carcinomas, which would further pave the way for future researchers in developing potent drugs for cancer management. MDPI 2023-07-12 /pmc/articles/PMC10385528/ /pubmed/37513529 http://dx.doi.org/10.3390/nu15143111 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Review Pandey, Pratibha Khan, Fahad Khan, Minhaj Ahmad Kumar, Rajnish Upadhyay, Tarun Kumar An Updated Review Summarizing the Anticancer Efficacy of Melittin from Bee Venom in Several Models of Human Cancers |
title | An Updated Review Summarizing the Anticancer Efficacy of Melittin from Bee Venom in Several Models of Human Cancers |
title_full | An Updated Review Summarizing the Anticancer Efficacy of Melittin from Bee Venom in Several Models of Human Cancers |
title_fullStr | An Updated Review Summarizing the Anticancer Efficacy of Melittin from Bee Venom in Several Models of Human Cancers |
title_full_unstemmed | An Updated Review Summarizing the Anticancer Efficacy of Melittin from Bee Venom in Several Models of Human Cancers |
title_short | An Updated Review Summarizing the Anticancer Efficacy of Melittin from Bee Venom in Several Models of Human Cancers |
title_sort | updated review summarizing the anticancer efficacy of melittin from bee venom in several models of human cancers |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10385528/ https://www.ncbi.nlm.nih.gov/pubmed/37513529 http://dx.doi.org/10.3390/nu15143111 |
work_keys_str_mv | AT pandeypratibha anupdatedreviewsummarizingtheanticancerefficacyofmelittinfrombeevenominseveralmodelsofhumancancers AT khanfahad anupdatedreviewsummarizingtheanticancerefficacyofmelittinfrombeevenominseveralmodelsofhumancancers AT khanminhajahmad anupdatedreviewsummarizingtheanticancerefficacyofmelittinfrombeevenominseveralmodelsofhumancancers AT kumarrajnish anupdatedreviewsummarizingtheanticancerefficacyofmelittinfrombeevenominseveralmodelsofhumancancers AT upadhyaytarunkumar anupdatedreviewsummarizingtheanticancerefficacyofmelittinfrombeevenominseveralmodelsofhumancancers AT pandeypratibha updatedreviewsummarizingtheanticancerefficacyofmelittinfrombeevenominseveralmodelsofhumancancers AT khanfahad updatedreviewsummarizingtheanticancerefficacyofmelittinfrombeevenominseveralmodelsofhumancancers AT khanminhajahmad updatedreviewsummarizingtheanticancerefficacyofmelittinfrombeevenominseveralmodelsofhumancancers AT kumarrajnish updatedreviewsummarizingtheanticancerefficacyofmelittinfrombeevenominseveralmodelsofhumancancers AT upadhyaytarunkumar updatedreviewsummarizingtheanticancerefficacyofmelittinfrombeevenominseveralmodelsofhumancancers |